Venture capital firm profile
Collab Capital
Collab Capital invests in United States startups developing technology that improves healthcare access, economic mobility and the infrastructure serving communities.

United States
Seed
Series A
Looks for a tested MVP and prefers products on the market with recurring revenue and evidence that customers will pay. Seeks strong teams and large, growing markets. Fund II first and follow-on checks range from $500K to $2M. Generally declines biotechnology, cannabis and tobacco, cryptocurrency and tokens, food and beverage, gambling, liquor and spirits, professional services agencies, physical retail and real estate. Cannot invest in or provide grants to charities.
Healthcare & Life Sciences
United States
Sources checked
Seed
Sources checked
Series A
Sources checked
Looks for a tested MVP and prefers products on the market with recurring revenue and evidence that customers will pay. Seeks strong teams and large, growing markets. Fund II first and follow-on checks range from $500K to $2M. Generally declines biotechnology, cannabis and tobacco, cryptocurrency and tokens, food and beverage, gambling, liquor and spirits, professional services agencies, physical retail and real estate. Cannot invest in or provide grants to charities.
Sources checked
Healthcare & Life Sciences
As of
Sources checked
Collab Capital backs seed and Series A businesses addressing community infrastructure, access to care and economic mobility. Its founder-led team pairs capital with practical coaching and connections, seeking entrepreneurs whose experience gives them insight into the problems they tackle. It evaluates companies across the United States.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Investment sectors
Healthcare & Life Sciences · Investment sectors
As of 2026-11-15
Collab Capital official sourceCollab Capital official sourceLoading recent changes…